20 Dec, EOD - Indian

SENSEX 78041.59 (-1.49)

Nifty 50 23587.5 (-1.52)

Nifty Bank 50759.2 (-1.58)

Nifty IT 43771.05 (-2.63)

Nifty Midcap 100 56906.75 (-2.82)

Nifty Next 50 68702.65 (-2.72)

Nifty Pharma 22501.85 (-0.86)

Nifty Smallcap 100 18714.3 (-2.19)

20 Dec, EOD - Global

NIKKEI 225 38701.9 (-0.29)

HANG SENG 19720.7 (-0.16)

S&P 6008.5 (1.05)

Login/Signup

You are Here : Home > Research

29-Oct-2024

Pfizer

PAT up 6.3%

'On standalone basis

Quarter ended September 2024 compared with Quarter ended September 2023.

Net sales (including other operating income) of Pfizer has increased 2.33% to Rs 588.59 crore.  Operating profit margin has jumped from 31.75% to 32.15%, leading to 3.64% rise in operating profit to Rs 189.25 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 15.71% to 14.32%.   Purchase of finished goods cost rose from 14.84% to 15.07%.   Employee cost increased from 16.84% to 18.83%.   Other expenses fell from 18.38% to 16.42%.   

Other income up 19.41% to Rs 43.07 crore.  PBIDT rose 6.24% to Rs 232.32 crore.  Provision for interest fell 23.08% to Rs 2.1 crore.  Loan funds declined from Rs 42.63 crore as of 30 September 2023 to Rs 36.94 crore as of 30 September 2024.  Inventories rose to Rs 454.82 crore as of 30 September ...



Pleaselogin & subscribe to view the full report.

More Reports
More Reports View Company Information

  • Results-Analysis   (29-Oct-2024)

    Pfizer

    PAT up 6.3%

  • Results-Analysis   (30-Jul-2024)

    Pfizer

    OP increased 60.32%

  • Results-Analysis   (28-Oct-2023)

    Pfizer

    PAT down 52.11%

  • Results-Analysis   (16-May-2023)

    Pfizer

    PAT up 3.07%